Assembly Biosciences, Inc.

NasdaqGS ASMB

Assembly Biosciences, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 3.31

Assembly Biosciences, Inc. Price to Sales Ratio (P/S) is 3.31 on January 14, 2025, a -54.88% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Assembly Biosciences, Inc. 52-week high Price to Sales Ratio (P/S) is 10.40 on March 08, 2024, which is 214.53% above the current Price to Sales Ratio (P/S).
Assembly Biosciences, Inc. 52-week low Price to Sales Ratio (P/S) is 2.87 on October 08, 2024, which is -13.09% below the current Price to Sales Ratio (P/S).
Assembly Biosciences, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 5.46.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqGS: ASMB

Assembly Biosciences, Inc.

CEO	Mr. Jason A. Okazaki
IPO Date	Dec. 17, 2010
Location	United States
Headquarters	331 Oyster Point Boulevard
Employees	65
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Key trends

Past 5 years